Promoter methylation of RASSF1A and DAPK and mutations of K-ras and p53 in non-small cell lung cancer patients

被引：0
|
作者：
Liu, Yang
Lan, Qing
Gao, Weimin
Siegfried, Jill
Luketich, James
Keohavong, Phouthone
机构：
[1] Univ Pittsburgh, Pittsburgh, PA USA
[2] NCI, NIH, DHHS, Bethesda, MD 20892 USA
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
51
引用
收藏
页数：1
相关论文
共 50 条
  • [41] The relationship between microvessel count and the expression of vascular endothelial growth factor, p53, and K-ras in non-small cell lung cancer
    Kang, YH
    Kim, KS
    Yu, YK
    Lim, SC
    Kim, YC
    Park, KO
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2001, 16 (04) : 417 - 423
  • [42] Correlation between DAPK Promoter Methylation and Gefitinib Sensitivity in Non-small Cell Lung Cancer
    Wu Weiqin
    Zhang Xiaoyuan
    Xu Haifeng
    Xu Jing
    Shen Jie
    Lu Kaihua
    JOURNAL OF INTERNATIONAL TRANSLATIONAL MEDICINE, 2013, 1 (04): : 152 - 157
  • [43] EGFR and K-Ras Gene Mutations in the Diagnosis of Non-Small Cell Lung Cancer and their Pathological Correlation
    Wu, Zhenhua
    Yibulayin, Waresijiang
    He, Dan
    Xu, Keming
    Yibulayin, Xiayimaierdan
    Ma, Lei
    Sun, Xiaohong
    INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2024, 20 (05) : 874 - 882
  • [44] Alterations of K-ras and p53 mutations in colorectal cancer patients in Central Europe
    König, EA
    Köves, I
    Rasinariu, A
    Popp, AR
    Kusser, WC
    Soyonki, K
    Kovács, A
    Glickman, BW
    Jeney, A
    Marcsek, ZL
    JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES, 2001, 62 (05): : 333 - 347
  • [45] CT Radiogenomic Characterization of EGFR, K-RAS, and ALK Mutations in Non-Small Cell Lung Cancer
    Rizzo, Stefania
    Petrella, Francesco
    Buscarino, Valentina
    De Maria, Federica
    Raimondi, Sara
    Barberis, Massimo
    Fumagalli, Caterina
    Spitaleri, Gianluca
    Rampinelli, Cristiano
    De Marinis, Filippo
    Spaggiari, Lorenzo
    Bellomi, Massimo
    EUROPEAN RADIOLOGY, 2016, 26 (01) : 32 - 42
  • [46] CT Radiogenomic Characterization of EGFR, K-RAS, and ALK Mutations in Non-Small Cell Lung Cancer
    Stefania Rizzo
    Francesco Petrella
    Valentina Buscarino
    Federica De Maria
    Sara Raimondi
    Massimo Barberis
    Caterina Fumagalli
    Gianluca Spitaleri
    Cristiano Rampinelli
    Filippo De Marinis
    Lorenzo Spaggiari
    Massimo Bellomi
    European Radiology, 2016, 26 : 32 - 42
  • [47] Methylation patterns and K-ras mutations in tumor and paired serum of resected non-small-cell lung cancer patients
    Ramirez, JL
    Sarries, C
    de Castro, PL
    Roig, B
    Queralt, C
    Escuin, D
    de Aguirre, I
    Sanchez, JM
    Manzano, JL
    Margelí, M
    Sanchez, JJ
    Astudillo, J
    Taron, M
    Rosell, R
    CANCER LETTERS, 2003, 193 (02) : 207 - 216
  • [48] Analysis of the prognostic role of plasmatic K-ras mutations in advanced non-small cell lung cancer (NSCLC) patients
    Sirera, R.
    Camps, C.
    Berrocal, A.
    Munoz-Navarro, M.
    Garcia-Gomez, R.
    Vinolas, N.
    Artal, A.
    Guillot, M.
    Taron, M.
    Rosell, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [49] Aberrant promoter methylation of RASSF1A in serum correlates with disease stage in small-cell lung cancer patients
    Nadal, Ernest
    Gallegos, Marc
    Palmero, Ramon
    Brao, Isabel
    Saldana, Juana
    Navarro, Valenti
    Rigo, Raul
    Llatjos, Roger
    Esteller, Laura
    Romeo, Marga
    Capella, Gabriel
    Cardenal, Felipe
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S550 - S551
  • [50] Lung cancer and past occupational exposure to asbestos -: Role of p53 and K-ras mutations
    Husgafvel-Pursiainen, K
    Karjalainen, A
    Kannio, A
    Anttila, S
    Partanen, T
    Ojajärvi, A
    Vainio, H
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1999, 20 (04) : 667 - 674
12345